HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study

Jean-David Zeitoun 1, 2 Jérémie H. Lefevre 3 Nicholas Downing 4 Henri Bergeron 5 Joseph S. Ross 6
1 Service de Gastroentérologie et nutrition [CHU Saint-Antoine]
2 Dpt proctologie [CHU Croix St Simon]
3 Hôpital Beaujon
4 Brigham and Women's Hospital [Boston]
5 CSO - Centre de sociologie des organisations (Sciences Po, CNRS)
6 YSM - Yale School of Medicine [New Haven, Connecticut]
Abstract : Regulatory review time has been associated with post-market medication safety issues in the United States. Our objective was to evaluate whether regulatory review time and near deadline approval are associated with post-market safety events (PMSEs) for novel medicines approved by the European Medicines Agency (EMA).
Keywords : European Medicines Agency drug approval government regulation
Document type :
Journal articles
Complete list of metadata
https://hal-sciencespo.archives-ouvertes.fr/hal-01521129
Contributor : Spire Sciences Po Institutional Repository Connect in order to contact the contributor
Submitted on : Thursday, May 11, 2017 - 2:45:27 PM
Last modification on : Friday, March 25, 2022 - 6:30:02 PM

Identifiers

Collections

CNRS | SCIENCESPO | CSO | UNIV-PARIS7 | UNIV-PARIS | SORBONNE-UNIVERSITE | SU-MEDECINE

Citation

Jean-David Zeitoun, Jérémie H. Lefevre, Nicholas Downing, Henri Bergeron, Joseph S. Ross. Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study. British Journal of Clinical Pharmacology, Wiley, 2015, 80 (4), pp.716 - 725. ⟨hal-01521129⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

135